$19.710
-1.709 (-8.67%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de NAMS por análisis de gráficos similares
Alphio's NAMS stock price prediction model matches the current NewAmsterdam Pharma Company NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $19.68 (-0.15%). The 1-week path is $20.78 (+5.45%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de NewAmsterdam Pharma Company NV?
NewAmsterdam Pharma is not a good buy right now due to its significant financial losses and negative market sentiment. The current price is $19.71, but the company reported a widening net loss of $64.1 million in Q2, which is a substantial increase from a $17.4 million loss in the same period last year. Additionally, the RSI is at 31.606, indicating that the stock is oversold, but this does not outweigh the risks associated with its declining revenue and high insider selling activity, which has increased by 113.69% over the last month. The forward P/E ratio is 119.05, indicating that the stock is overvalued compared to its earnings potential, and the recent analyst downgrade reflects caution regarding the company's future performance.
NAMS cerró en $19.71 el Friday, tras bajar -8.67%
NewAmsterdam Pharma Company NV (NAMS) last closed at $19.71, losing -8.67%. These facts feed the 1-day and 1-week NAMS price prediction above.
Factores de la previsión
Los factores de la previsión de NewAmsterdam Pharma Company NV (NAMS) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de NAMS, ordenadas por similitud.
Análisis de estacionalidad de NAMS
Historically the probability of a positive October return for NAMS is 73.02%. November offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de NAMS
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Oct 2026 | $24.81 | $32.88 | $41.42 | +66.80% |
| Nov 2026 | $33.96 | $41.82 | $49.82 | +112.17% |
| Dec 2026 | $33.82 | $41.16 | $42.47 | +108.81% |
En 2026, se proyecta que NewAmsterdam Pharma Company NV (NAMS) oscile entre $24.81 y $49.82.
Previsión mensual de NewAmsterdam Pharma Company NV para 2026
En Oct de 2026, se proyecta que NewAmsterdam Pharma Company NV promedie $32.88, con un mínimo de $24.81 y un máximo de $41.42.
En Nov de 2026, se proyecta que NewAmsterdam Pharma Company NV promedie $41.82, con un mínimo de $33.96 y un máximo de $49.82.
En Dec de 2026, se proyecta que NewAmsterdam Pharma Company NV promedie $41.16, con un mínimo de $33.82 y un máximo de $42.47.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.